Micron Pure, LLC

OLATHE, KS · Founded 2020 · Medtech · Private

FDA-cleared medical device using closed-loop UV-C light and ozone system to neutralize pathogens and bacteria

Claim this profile

Follows are private to you and power your alerts

Updated · micronpure.com

Sector
Medtech
Headquarters
OLATHE, KS
Founded
2020
Latest Form D
$150K, Mar 2024
Total capital
$400K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$400K
2 Form D · last Mar 2024
31 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
5 pending · first 2021
Rank in peer group#370 of 1112

Capital timeline

202220232024FEDERAL ↑EQUITY ↓Cumulative $400K1st Form D$250K2nd Form D$150K
202220232024FEDERAL ↑EQUITY ↓Cumulative $400K1st Form D$250K2nd Form D$150K

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$150K
  • Private capital raisedForm D · SEC · 1st filing$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#370 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • David Anthony LeavittResearcherDirectorLinked by 3 patents
  • Jason Anthony MannelloDirectorNamed in SEC Form D filings
  • John Robert BergidaExecutive Officer, DirectorNamed in SEC Form D filings
  • Joseph Anthony BergidaDirectorNamed in SEC Form D filings
  • Parker Anthony CondieDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 8
Show all 8 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .